Chronic Myelogenous Leukemia

Alfonso Quintás-Cardama, Jorge Cortes, Hagop Kantarjian, Susan O'Brien

Research output: Chapter in Book/Report/Conference proceedingChapter

Original languageEnglish (US)
Title of host publicationMolecular Hematology
Subtitle of host publicationThird Edition
PublisherWiley-Blackwell
Pages76-88
Number of pages13
ISBN (Print)9781405182317
DOIs
StatePublished - Mar 10 2010
Externally publishedYes

Keywords

  • BCR-ABL 1 kinase signaling pathways
  • BP CML, characterized by prominent hypercatabolic symptoms
  • Chronic myelogenous leukemia
  • Chronic myeloid leukemia (CML), clonal myeloproliferative neoplasm from pluripotent stem cell
  • Emergence of imatinib mesylate -change in therapeutic algorithm for CML
  • Genome-wide analyses of gene expression profiles -prognostication tools in multiple malignancies
  • Imatinib resistance -categorized as primary (also "refractoriness")
  • Signaling pathways activated by BCR-ABL1 kinase
  • Stem cell transplantation -allogeneic SCT, therapeutic modality for patients with human leukocyte antigen (HLA)-identical siblings

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Quintás-Cardama, A., Cortes, J., Kantarjian, H., & O'Brien, S. (2010). Chronic Myelogenous Leukemia. In Molecular Hematology: Third Edition (pp. 76-88). Wiley-Blackwell. https://doi.org/10.1002/9781444318531.ch7

Chronic Myelogenous Leukemia. / Quintás-Cardama, Alfonso; Cortes, Jorge; Kantarjian, Hagop; O'Brien, Susan.

Molecular Hematology: Third Edition. Wiley-Blackwell, 2010. p. 76-88.

Research output: Chapter in Book/Report/Conference proceedingChapter

Quintás-Cardama, A, Cortes, J, Kantarjian, H & O'Brien, S 2010, Chronic Myelogenous Leukemia. in Molecular Hematology: Third Edition. Wiley-Blackwell, pp. 76-88. https://doi.org/10.1002/9781444318531.ch7
Quintás-Cardama A, Cortes J, Kantarjian H, O'Brien S. Chronic Myelogenous Leukemia. In Molecular Hematology: Third Edition. Wiley-Blackwell. 2010. p. 76-88 https://doi.org/10.1002/9781444318531.ch7
Quintás-Cardama, Alfonso ; Cortes, Jorge ; Kantarjian, Hagop ; O'Brien, Susan. / Chronic Myelogenous Leukemia. Molecular Hematology: Third Edition. Wiley-Blackwell, 2010. pp. 76-88
@inbook{34f8c2fe12a740c095408bd43aacf65d,
title = "Chronic Myelogenous Leukemia",
keywords = "BCR-ABL 1 kinase signaling pathways, BP CML, characterized by prominent hypercatabolic symptoms, Chronic myelogenous leukemia, Chronic myeloid leukemia (CML), clonal myeloproliferative neoplasm from pluripotent stem cell, Emergence of imatinib mesylate -change in therapeutic algorithm for CML, Genome-wide analyses of gene expression profiles -prognostication tools in multiple malignancies, Imatinib resistance -categorized as primary (also {"}refractoriness{"}), Signaling pathways activated by BCR-ABL1 kinase, Stem cell transplantation -allogeneic SCT, therapeutic modality for patients with human leukocyte antigen (HLA)-identical siblings",
author = "Alfonso Quint{\'a}s-Cardama and Jorge Cortes and Hagop Kantarjian and Susan O'Brien",
year = "2010",
month = "3",
day = "10",
doi = "10.1002/9781444318531.ch7",
language = "English (US)",
isbn = "9781405182317",
pages = "76--88",
booktitle = "Molecular Hematology",
publisher = "Wiley-Blackwell",
address = "United States",

}

TY - CHAP

T1 - Chronic Myelogenous Leukemia

AU - Quintás-Cardama, Alfonso

AU - Cortes, Jorge

AU - Kantarjian, Hagop

AU - O'Brien, Susan

PY - 2010/3/10

Y1 - 2010/3/10

KW - BCR-ABL 1 kinase signaling pathways

KW - BP CML, characterized by prominent hypercatabolic symptoms

KW - Chronic myelogenous leukemia

KW - Chronic myeloid leukemia (CML), clonal myeloproliferative neoplasm from pluripotent stem cell

KW - Emergence of imatinib mesylate -change in therapeutic algorithm for CML

KW - Genome-wide analyses of gene expression profiles -prognostication tools in multiple malignancies

KW - Imatinib resistance -categorized as primary (also "refractoriness")

KW - Signaling pathways activated by BCR-ABL1 kinase

KW - Stem cell transplantation -allogeneic SCT, therapeutic modality for patients with human leukocyte antigen (HLA)-identical siblings

UR - http://www.scopus.com/inward/record.url?scp=84885786072&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885786072&partnerID=8YFLogxK

U2 - 10.1002/9781444318531.ch7

DO - 10.1002/9781444318531.ch7

M3 - Chapter

AN - SCOPUS:84885786072

SN - 9781405182317

SP - 76

EP - 88

BT - Molecular Hematology

PB - Wiley-Blackwell

ER -